BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27561844)

  • 1. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
    Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome.
    Jones RP; Stättner S; Dunne DF; O'Grady E; Smethurst A; Terlizzo M; Malik HZ; Fenwick SW; Poston GJ
    Eur J Surg Oncol; 2013 Oct; 39(10):1122-8. PubMed ID: 23928482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N; Akinwande O; Martin RC
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
    Pernot S; Artru P; Mithieux F; Marsot J; Watkin E; Pellerin O; Lledo G; Chalabreysse P; Desramé J; Taieb J
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
    Richardson AJ; Laurence JM; Lam VW
    J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series.
    Jones RP; Dunne D; Sutton P; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Koelblinger C; Stättner S; Stremitzer S; Gruenberger T; Poston GJ
    HPB (Oxford); 2013 Jan; 15(1):71-7. PubMed ID: 23216781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Akinwande O; Scoggins C; Martin RC
    Anticancer Res; 2016 Jul; 36(7):3413-8. PubMed ID: 27354601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
    Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
    Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
    Huppert P; Wenzel T; Wietholtz H
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization.
    Scevola G; Loreni G; Rastelli M; Sposato S; Ramponi S; Miele V
    Med Oncol; 2017 Mar; 34(3):37. PubMed ID: 28160267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients.
    Ngo A; von Stempel C; Corbo B; Bandula S; Shiu KK; Raja J; Hague J; Evans J; Kibrya N
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):979-990. PubMed ID: 31044294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
    Iezzi R; Marsico VA; Guerra A; Cerchiaro E; Cassano A; Basso M; Devicienti E; Rodolfino E; Barone C; Bonomo L
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1523-31. PubMed ID: 25799948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.
    Martin RC; Joshi J; Robbins K; Tomalty D; Bosnjakovik P; Derner M; Padr R; Rocek M; Scupchenko A; Tatum C
    Ann Surg Oncol; 2011 Jan; 18(1):192-8. PubMed ID: 20740319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study.
    Bower M; Metzger T; Robbins K; Tomalty D; Válek V; Boudný J; Andrasina T; Tatum C; Martin RC
    HPB (Oxford); 2010 Feb; 12(1):31-6. PubMed ID: 20495642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic review.
    Akinwande O; Dendy M; Ludwig JM; Kim HS
    Surg Oncol; 2017 Sep; 26(3):268-275. PubMed ID: 28807246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases.
    Sljivic M; Sever M; Ocvirk J; Mesti T; Brecelj E; Popovic P
    Radiol Oncol; 2024 Jun; 58(2):214-220. PubMed ID: 38553252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.
    Carling U; Dorenberg EJ; Haugvik SP; Eide NA; Berntzen DT; Edwin B; Dueland S; Røsok B
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1532-41. PubMed ID: 25832764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
    Martin RC; Scoggins CR; Schreeder M; Rilling WS; Laing CJ; Tatum CM; Kelly LR; Garcia-Monaco RD; Sharma VR; Crocenzi TS; Strasberg SM
    Cancer; 2015 Oct; 121(20):3649-58. PubMed ID: 26149602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease.
    Young S; D'Souza D; Flanagan S; Golzarian J
    Cardiovasc Intervent Radiol; 2017 Apr; 40(4):496-501. PubMed ID: 28004168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
    Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
    Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.